BioNotebook: Controversial StemCells board appointment; Portola/Daiichi Sankyo, Lexicon/JDRF, Supernus; and stock offerings

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.